Gene Query: MPP7

Dataset Description Geneva Score
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 48.57
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 48.57
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 41.67
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 41.4
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 39.99
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 38.53
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 37.18
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 37.18
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 36.25
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 34.79
RNA-seq of human aneuploid cell lines with Trisomy 21 34.67
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 32.87
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 32.87
WRN knockout effects upon gene expression in SW48 and OVK18 29.95
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 29.63
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 29.47
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 28.43
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 28.33
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 28.33
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 27.82
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 27.79
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 26.92
Crizotinib v. DMSO in SW480 cells 26.16
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 25.44
Uridylation by TUT4 and TUT7 marks mRNA for degradation 25.16
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 24.74
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 24.26
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 22.81
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 22.61
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 22.61
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 21.95
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 21.95
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 21.26
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 20.94
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 20.62
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 19.85
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 19.53
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 18.39
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 18.12
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 17.88
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 17.82
Proliferation-correlated expression 17.57
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 17.43
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 17.39
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 16.89
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 16.89
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 16.15
RNA sequencing analysis of selumetinib-resistant CRC cells lines 16.12
ARID1A and ARID1B loss in HCT116 cells 16.03
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 15.48
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 15.45
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 15.14
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 15.14
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 14.98
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 14.77
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 14.42
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 14.35
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 14.35
RNA-sequencing of formalin fixed human primary melanoma tissue 14.22
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 14.05
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 13.9
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 13.77
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 13.58
Cajal bodies are linked to genome conformation [RNA-Seq] 13.1
Cajal bodies are linked to genome conformation 13.1
RNA-seq of stable and unstable section of human atherosclerotic plaques 12.97
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 12.93
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 12.9
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 12.63
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 12.44
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 12.34
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 11.95
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 11.78
CircRNAome diversity in human mature B-cells, T-cells and monocytes 11.78
Integrin signaling regulates YAP/TAZ to control skin homeostasis 11.77
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 11.48
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 11.37
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 11.33
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 10.95
Gene expression profile in breast cancer cell lines using RNA sequencing 10.84
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 10.76
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 10.74
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 10.02
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 9.88
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 9.78
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 9.78
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 9.65
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 9.6
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 9.48
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 9.39
Gene Expression Profiling of WT and KDM3A Knocked out Cell 9.39
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 9.38
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 9.37
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 9.29
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 9.26
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 9.26
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 9.24
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 9.24
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 9.17
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 9.17
RNA sequencing of primary human platelets and in vitro cell lines 9.03
Regulation of Lipids is Central to Replicative Senescence 8.98
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 8.91
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 8.89
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 8.87
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 8.86
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 8.79
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 8.79
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 8.76
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 8.76
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 8.71
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 8.66
Gene expression analysis of the impact of TDP-43 knockout in human cells. 8.59
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 8.4
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 8.4
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 8.03
Nutritional control of protein translation 7.94
Real-time observation of light-controlled transcription in living cells 7.87
ARS2 is a general suppressor of pervasive transcription [RNAseq] 7.85
The Genomic Landscape of Atypical Fibroxanthoma 7.79
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 7.76
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 7.73
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 7.68
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 7.67
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 7.65
RNA-seq analysis and shRNA screen of breast cancer 7.59
RNA-seq analysis of breast cancer 7.59
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 7.48
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 7.47
LncRNA-GAS5 negative regulation of YAP-target genes expression 7.39
Morphological and molecular characterization of human dermal lymphatic collectors 7.36
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 7.35
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 7.25
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 7.24
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 7.17
IDH3a KO RNA-seq 7.12
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 6.97
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 6.97
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 6.96
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 6.96
EWSR1 influences alternative splicing through direct and indirect mechanisms 6.94
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 6.86
Non-coding regions are the main source of tumor-specific antigens 6.63
Non-coding regions are the main source of tumor-specific antigens [human] 6.63
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 6.58
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 6.56
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 6.56
Energy Metabolism during Anchorage-Independence 6.52
Transcriptome of diurnal human blood neutrophils 6.51
T47D RNA-seq and ChrRNA-seq data 6.48
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 6.48
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 6.2
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 6.19
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 6.09
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 6.09
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 5.99
Transcriptome landscape of HeLa response upon triamcinolone acetonide 5.93
Global epigenomic reconfiguration during mammalian brain development 5.91
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 5.89
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 5.89
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 5.85
Identification of global regulators of T-helper cell lineage specification 5.85
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 5.82
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 5.8
Fusion discovery in breast cancer cell line 5.79
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 5.76
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 5.76
Interaction between mitoNEET and NAF-1 in cancer cells 5.65
Transcriptomes of human monocytes after ex vivo exposure to uric acid 5.62
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 5.61
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 5.58
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 5.57
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 5.54
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 5.54
Oncogenic MYC induces a dependency on the spliceosome in human cancer 5.47
Identification of long noncoding RNAs regulated by p53 5.45
Genome-wide discovery of human splicing branchpoints [RNAse] 5.43
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 5.41
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 5.37
Transcriptome analysis of virus infected tissues 5.35
High-throughput sequencing of PROMPT-enriched samples. 5.33
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 5.32
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 5.31
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 5.28
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 5.28
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 5.2
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 5.16
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 5.15
U1 snRNP telescripting regulates size-function stratified human genome 5.14
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 5.09
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 5.08
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 5.07
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 5.04
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 5.02
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 4.98
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 4.9
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 4.88
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 4.87
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 4.85
Transcriptome analysis of human lung epithelial cells 4.82
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 4.8
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 4.79
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 4.77
Genome-wide discovery of human splicing branchpoints 4.76
RNA-seq differential expression studies: more sequence, or more replication? 4.72
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 4.65
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 4.65
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 4.64
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 4.63
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 4.62
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 4.58
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 4.55
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 4.55
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 4.54
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 4.53
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 4.52
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 4.52
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 4.44
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 4.41
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 4.37
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 4.36
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 4.36
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 4.36
Transcriptome of activated human and mouse MAIT cells 4.36
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 4.35
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 4.35
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 4.27
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 4.27
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 4.25
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 4.25
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 4.2
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 4.2
Gene expression profile of human placenta from T. Cruzi infected mothers 4.16
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 4.12
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 4.11
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 4.1
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 4.08
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 4.08
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 4.08
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 4.06
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 4.05
FBXW7 modulates stress response by post-translational modification of HSF1 4.01
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 4.01
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 4.01
Modeling Human Cancer-induced Cachexia (Human) 3.99
The role of the Calcium-Sensing receptor in colorectal cancer 3.97
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 3.95
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 3.93
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 3.93
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 3.91
Transcriptome-wide identification of CELF2 functional targets in T cells 3.84
Transcriptional profile in human S. haematobium infection 3.83
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 3.82
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 3.8
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 3.79
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 3.75
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 3.73
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 3.69
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 3.69
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 3.67
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 3.65
Paxillin regulates genomic networks in prostate cancer [LNCaP] 3.64
TOP2B disturbed the quality of human oocytes with advanced maternal age 3.64
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 3.63
MCF-7 as a model for functional analysis of breast cancer risk variants 3.6
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 3.57
MOF acetyl transferase regulates transcription and respiration in mitochondria 3.54
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.53
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.53
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 3.53
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 3.52
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 3.51
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 3.5
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 3.5
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 3.49
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 3.49
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 3.47
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 3.47
Knockdown of ADNP in HCT116 colon cancer cells 3.46
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 3.46
Genes significantly down or Up-regulated upon RNF219 knockdown 3.44
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 3.43
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 3.43
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 3.42
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 3.4
RNA-seq of resting and activated CD4+ T cells +-JQ1 3.39
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 3.35
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 3.31
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 3.3
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 3.29
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 3.27
Transcriptome-wide response to synthetic chromatin protein PcTF 3.25
Gene expression profile difference among renal location in a stone former 3.25
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 3.24
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 3.2
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 3.15
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 3.15
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 3.14
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 3.11
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 3.09
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 3.01
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 3.0
Expression patterns in chronic thromboembolic pulmonary hypertension 2.99
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 2.98
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 2.96
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 2.96
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 2.93
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 2.92
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 2.92
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 2.92
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 2.92
mRNA recovered upon RNF219 IP. [RNA-IP] 2.92
Effect of ILF3 on translation during homeostasis and the antiviral response 2.91
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 2.91
hnRNP C is a key regulator of protein synthesis in mitosis 2.9
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 2.88
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 2.84
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 2.83
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 2.83
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 2.83
mRNA sequencing of oropharyngeal cancer cell lines 2.82
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 2.82
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 2.82
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 2.8
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 2.8
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 2.76
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 2.71
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 2.66
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 2.6
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 2.6
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 2.6
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 2.58
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 2.58
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 2.55
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 2.52
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 2.46
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 2.46
mRNA expression profile of Lymphocytes 2.46
Searching for target genes of miR-508/509/506/514 in HCT116 cells 2.44
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 2.44
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 2.44
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 2.44
RNAseq of Breast cancer PDX samples 2.43
PTHrP overexpression in MCF7 cells 2.41
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 2.4
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 2.4
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 2.39
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 2.38
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 2.37
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 2.36
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 2.34
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 2.29
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 2.28
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 2.24
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 2.24
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 2.24
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 2.24
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 2.22
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 2.2
Finding missing proteins from epigenetically manipulated human cells 2.17
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 2.13
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 2.09
Reprogrammed myeloid cell transcriptomes in NSCLC 2.07
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 2.02
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 2.01
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 2.0
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 1.98
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 1.97
Gene expression analysis upon mtDNA depletion 1.97
Gene expression analysis upon mtDNA depletion [RNA-seq] 1.97
Conservative alteration of chromosomal expression pattern across human solid tumor types 1.96
Age-Related Gene Expression Changes in Prostate Cancer Patients 1.95
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 1.95
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 1.9
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 1.88
The transcriptome effect of overexpressing EZH2 in MCF7 1.86
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 1.8
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 1.79
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 1.76
naive T cell heterogeneity after neonatal thymectomy 1.76
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 1.71
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 1.69
RNAseq analysis of ruxolitinib treated breast cancers 1.66
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 1.61
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.61
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 1.59
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 1.57
ARID1A and ARID1B loss in HCT116 and TOV21G cells 1.57
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 1.56
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.55
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 1.55
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 1.55
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 1.54
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 1.5
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.48
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 1.46
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 1.46
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 1.46
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 1.44
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 1.44
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 1.42
RNAseq of cell lines with knocked in ESR1 mutations 1.42
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 1.37
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 1.33
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 1.3
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.29
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 1.27
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 1.27
RNA seq analysis of human Fetal and adult derived Enterospheres 1.24
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 1.24
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 1.23
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 1.23
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 1.23
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 1.2
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 1.19
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.18
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 1.18
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 1.18
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.09
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.08
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 1.08
Mitochondrial dsRNA triggers antiviral signalling in humans 1.07
SOX11 knockdown in B-ALL cell lines 1.07
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 1.04
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 1.03
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 0.99
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 0.99
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.96
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 0.96
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 0.95
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 0.92
Total RNA-Seq data from leukemic patients with complex structural variants 0.91
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.91
quanTIseq: quantifying immune contexture of human tumors 0.91
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.89
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.88
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.88
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 0.85
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 0.83
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.82
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 0.77
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 0.76
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.74
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.74
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.74
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 0.72
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 0.72
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.7
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 0.66
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.63
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.62
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 0.62
Gene expression analysis of breast cancer cell-lines 0.6
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.6
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.59
Human islets of varying quality: the good, the (not so) bad and the ugly 0.59
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 0.58
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 0.58
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 0.57
Persistence of stem cell metabolism in cancers as a failure of differentiation 0.54
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.49
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.44
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.44
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 0.43
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.42
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.42
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 0.41
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 0.41
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.41
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 0.4
p63 controls the enhancer landscape during keratinocyte differentiation 0.4
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 0.37
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.37
Characterization of human ILC2 subsets 0.37
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 0.36
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 0.36
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 0.35
Preclinical model of obesity and ER-positive breast cancer 0.34
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 0.3
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.23
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.2
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.17
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.16
RNA-Seq in neutrophils from Antiphospholipid Syndrome 0.14
Transcriptome analysis of peripheral blood monocytes 0.11
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.1
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 0.08
BASP1 modifies the Tamoxifen response 0.08
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 0.07
Gene expression changes due to PARP knockdown in human cells 0.06
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.05
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.05
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 0.05
Aging-associated patterns in the expression of human endogenous retroviruses 0.04
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.03
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.03
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.03
ML29755 RNA-seq data 0.01
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.01
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation